HPWM
TECH icon

Highland Private Wealth Management’s Bio-Techne TECH Stock Holding History

Highland Private Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,004
Closed -$217K – 202
2022
Q1 		$217K Buy
2,004
+72
+4% +$7.43K 0.03% 176
2021
Q4 		$250K Hold
1,932
– – 0.03% 160
2021
Q3 		$234K Buy
1,932
+40
+2% +$4.87K 0.03% 159
2021
Q2 		$213K Buy
+1,892
New +$199K 0.03% 162

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Highland Private Wealth Management's TECH Position: Q2 2022 in Review

Highland Private Wealth Management sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 2,004 shares — an estimated $217K sold.

Highland Private Wealth Management first reported a position in TECH in Q2 2021 and held it in 4 quarters. The position peaked at $250K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

  • Highland Private Wealth Management reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
  • Highland Private Wealth Management sold 2,004 Bio-Techne shares in Q2 2022, an estimated $217K.
  • Highland Private Wealth Management first reported a position in Bio-Techne in Q2 2021 and held it in 4 quarters.
  • Highland Private Wealth Management's Bio-Techne position peaked at $250K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on Highland Private Wealth Management's 13F filing for Q2 2022, filed 14 Jul 2022.